CalciumHydroxylapatiteQualityChecker

Calcium Hydroxylapatite

dermal fillers endotoxins heavy metals hyaluronic acid impurities injectables microbiology particles

Calcium Hydroxylapatite Quality Checker — Calcium Hydroxylapatite (CaHA) Dermal Fillers (Radiesse type) (ISO 13485, EU MDR)

ℹ️  The utility checks CaHA content, microsphere size, agglomerates presence, carrier gel rheology, extrusion force, impurities, sterility, endotoxins.
ℹ️  Does not use machine learning — rule-based logic only.
⚠️  CRITICAL for implantable fillers! Particle size (25–45 µm) and absence of agglomerates are critical to prevent granulomas and embolism. Sterility and endotoxins are mandatory!

Usage:
  CalciumHydroxylapatiteQualityChecker.exe                            → demo mode (console output)
  CalciumHydroxylapatiteQualityChecker.exe input.csv output.json      → evaluate your data

Input format (single row of data):
BatchNumber,CaHA_Content_Percent,MicrosphereSize_um,Agglomerates_Percent,CarrierGel_pH,Viscosity_Pa_s,Syringeability_Force_N,Impurity_FreeCalcium_ppm,Impurity_HeavyMetals_ppm,Endotoxin_EU_ml,SterilityTest,PackagingIntegrityTest,EthanolPPM,AcetonePPM

Example (SterilityTest/PackagingIntegrityTest: 0=pass, 1=fail):
CAHA-FILL-2026-001,30.0,32.0,0.5,7.0,18.0,12.0,20,5,0.2,0,0,600,400

— WHY IS THIS NEEDED?
Calcium Hydroxylapatite (CaHA) dermal fillers — injectable products for volume correction, lifting, and collagen biostimulation:
• Radiesse, Merz Aesthetics (30% CaHA microspheres in gel carrier)
• Synthetic CaHA microspheres (25–45 µm) suspended in aqueous gel (carboxymethylcellulose, glycerin)
• Provide immediate volume + long-term neocollagenesis stimulation
⚠️ CRITICAL:
• Microsphere size 25–45 µm — optimal range: particles <25 µm may be phagocytosed (fast degradation), >45 µm visible under skin or cause inflammation
• Agglomerates ≤ 1% — critical! Clumps of microspheres lead to granulomas, irregularities, and risk of vascular embolism during injection
• CaHA Content 30% ± — ensures balance between volume and biostimulation
• Extrusion force ≤ 15.0 N — filler must pass easily through thin needles (27G, 30G) without gel structure damage
• Sterility — MANDATORY for implantable products (USP <71> test)
• Endotoxins ≤ 0.5 EU/mL — critical to prevent severe inflammatory reactions and tissue necrosis (LAL test per USP <85>)
• pH 6.5–7.5 — physiological range, minimizes injection pain and ensures gel stability
⚠️ Special attention: CaHA fillers are medical devices risk class III (in EU per MDR). Particle size control performed by laser diffraction or microscopy. Agglomerates checked visually or by automated image analysis. Carrier gel biodegrades in few months, leaving CaHA microspheres as scaffold for new collagen. Sterility and apyrogenicity critical as product injected deep into dermis/subcutaneous tissue!
Critical parameters:
• CaHA Content: 28.0–32.0% (30% ±)
• Microsphere Size: 25.0–45.0 µm
• Agglomerates: ≤ 1.0%
• Gel pH: 6.5 – 7.5
• Viscosity: 10.0 – 30.0 Pa·s
• Extrusion Force: ≤ 15.0 N
• Free Calcium: ≤ 50 ppm
• Heavy Metals: ≤ 10 ppm
• Endotoxins: ≤ 0.5 EU/mL
• Sterility: no microbial growth
• Packaging Integrity: no compromise
• Residual solvents: ethanol ≤ 5000 ppm, acetone ≤ 5000 ppm
⚠️ Note: CaHA microspheres synthesized chemically, then suspended in gel. Control of free calcium ions important to prevent premature coagulation or irritation. Agglomerates are main enemy of CaHA filler quality, their presence unacceptable in clinical practice. Sterility ensured by terminal sterilization or aseptic filling. Endotoxins controlled at all stages of water and raw material production.

input.csv

BatchNumber,CaHA_Content_Percent,MicrosphereSize_um,Agglomerates_Percent,CarrierGel_pH,Viscosity_Pa_s,Syringeability_Force_N,Impurity_FreeCalcium_ppm,Impurity_HeavyMetals_ppm,Endotoxin_EU_ml,SterilityTest,PackagingIntegrityTest,EthanolPPM,AcetonePPM
CAHA-FILL-2026-001,30.0,32.0,0.5,7.0,18.0,12.0,20,5,0.2,0,0,600,400

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: CalciumHydroxylapatiteQualityCheckerAPI / object: Calcium HydroxylapatiteCategory: Dermal fillers

1. Scope

The Calcium Hydroxylapatite Quality Checker utility is used for Calcium Hydroxylapatite. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Dermal fillers

Tags: dermal fillers, endotoxins, heavy metals, hyaluronic acid, impurities, injectables, microbiology, particles, residual solvents, rheology, sterility, water quality

2. Execution modes

CalciumHydroxylapatiteQualityChecker.exe                            → demo mode (console output)
CalciumHydroxylapatiteQualityChecker.exe input.csv output.json      → evaluate your data

3. Key controlled areas

assay / content
purity and impurities
residual solvents
microbiology and pathogens
heavy metals / elemental impurities
pH and physicochemical parameters

4. Domain limits and critical parameters

⚠️ CRITICAL for implantable fillers! Particle size (25–45 µm) and absence of agglomerates are critical to prevent granulomas and embolism. Sterility and endotoxins are mandatory!
⚠️ CRITICAL:
Microsphere size 25–45 µm — optimal range: particles <25 µm may be phagocytosed (fast degradation), >45 µm visible under skin or cause inflammation
Agglomerates ≤ 1% — critical! Clumps of microspheres lead to granulomas, irregularities, and risk of vascular embolism during injection
CaHA Content 30% ± — ensures balance between volume and biostimulation
Extrusion force ≤ 15.0 N — filler must pass easily through thin needles (27G, 30G) without gel structure damage
Sterility — MANDATORY for implantable products (USP <71> test)
Endotoxins ≤ 0.5 EU/mL — critical to prevent severe inflammatory reactions and tissue necrosis (LAL test per USP <85>)
pH 6.5–7.5 — physiological range, minimizes injection pain and ensures gel stability
⚠️ Special attention: CaHA fillers are medical devices risk class III (in EU per MDR). Particle size control performed by laser diffraction or microscopy. Agglomerates checked visually or by automated image analysis. Carrier gel biodegrades in few months, leaving CaHA microspheres as scaffold for new collagen. Sterility and apyrogenicity critical as product injected deep into dermis/subcutaneous tissue!
Critical parameters:
CaHA Content: 28.0–32.0% (30% ±)
Microsphere Size: 25.0–45.0 µm
Agglomerates: ≤ 1.0%
Gel pH: 6.5 – 7.5
Viscosity: 10.0 – 30.0 Pa·s
Extrusion Force: ≤ 15.0 N
Free Calcium: ≤ 50 ppm
Heavy Metals: ≤ 10 ppm
Endotoxins: ≤ 0.5 EU/mL
Sterility: no microbial growth
Packaging Integrity: no compromise
Residual solvents: ethanol ≤ 5000 ppm, acetone ≤ 5000 ppm
⚠️ Note: CaHA microspheres synthesized chemically, then suspended in gel. Control of free calcium ions important to prevent premature coagulation or irritation. Agglomerates are main enemy of CaHA filler quality, their presence unacceptable in clinical practice. Sterility ensured by terminal sterilization or aseptic filling. Endotoxins controlled at all stages of water and raw material production.

Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

ID	Requirement	Criticality	Acceptance criterion
URS-001	The system shall accept an `input.csv` file for Calcium Hydroxylapatite with the exact columns listed in the “Input data contract” section.	High	A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002	The system shall support execution without arguments in demo mode and execution with `input.csv output.json` for user data.	Medium	Both execution scenarios produce a predictable result or clear diagnostic error.
URS-003	The system shall perform rule-based controls for: assay / content, purity and impurities, residual solvents, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters.	High	Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004	The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.	High	Output includes batch identifier, source values, parameter statuses and critical findings.
URS-005	The system shall generate machine-readable `output.json` for LIMS/ELN/MES, batch record and QA/QC review.	High	JSON contains overall status, check array, warnings, failures and source-file reference.
URS-006	The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.	High	The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007	The system shall clearly separate technical data errors from specification nonconformities.	Medium	Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#	Column	Type	Unit	Description	Sample	Control rule
1	`BatchNumber`	identifier	as specified	Batch Number	`CAHA-FILL-2026-001`	mandatory field; used for batch/lot traceability
2	`CaHA_Content_Percent`	decimal	%	Ca HA Content %	`30.0`	numeric value; compared with assay/purity limit from specification or method
3	`MicrosphereSize_um`	decimal	µm	Microsphere Size um	`32.0`	mandatory numeric value; rule comparison is performed by the utility
4	`Agglomerates_Percent`	decimal	%	Agglomerates %	`0.5`	mandatory numeric value; rule comparison is performed by the utility
5	`CarrierGel_pH`	decimal	pH	Carrier Gel p H	`7.0`	mandatory numeric value; rule comparison is performed by the utility
6	`Viscosity_Pa_s`	decimal	as specified	Viscosity Pa s	`18.0`	mandatory numeric value; rule comparison is performed by the utility
7	`Syringeability_Force_N`	decimal	as specified	Syringeability Force N	`12.0`	mandatory numeric value; rule comparison is performed by the utility
8	`Impurity_FreeCalcium_ppm`	decimal	ppm	Impurity Free Calcium ppm	`20`	numeric value; compared with individual or total impurity limit
9	`Impurity_HeavyMetals_ppm`	decimal	ppm	Impurity Heavy Metals ppm	`5`	numeric value; compared with individual or total impurity limit
10	`Endotoxin_EU_ml`	decimal	as specified	Endotoxin EU ml	`0.2`	numeric value; critical safety attribute compared with endotoxin limit
11	`SterilityTest`	boolean / flag	0/1	Sterility Test	`0`	valid flag required; prohibited organisms and growth are normally expected as 0 / absent
12	`PackagingIntegrityTest`	decimal	as specified	Packaging Integrity Test	`0`	mandatory numeric value; rule comparison is performed by the utility
13	`EthanolPPM`	decimal	ppm	Ethanol PPM	`600`	numeric value; checked as residual solvent against the applicable limit
14	`AcetonePPM`	decimal	ppm	Acetone PPM	`400`	numeric value; checked as residual solvent against the applicable limit

CSV example

BatchNumber,CaHA_Content_Percent,MicrosphereSize_um,Agglomerates_Percent,CarrierGel_pH,Viscosity_Pa_s,Syringeability_Force_N,Impurity_FreeCalcium_ppm,Impurity_HeavyMetals_ppm,Endotoxin_EU_ml,SterilityTest,PackagingIntegrityTest,EthanolPPM,AcetonePPM
CAHA-FILL-2026-001,30.0,32.0,0.5,7.0,18.0,12.0,20,5,0.2,0,0,600,400

7. FS — functional specification

ID	Function	Implementation description
FS-001	CLI entry point	The executable `CalciumHydroxylapatiteQualityChecker.exe` supports demo mode and `input.csv output.json` processing mode.
FS-002	CSV parser	The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003	Field conversion	Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004	Domain rule engine	For Calcium Hydroxylapatite, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005	Criticality handling	Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006	JSON writer	`output.json` stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007	Integration contract	The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008	Error handling	Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "CalciumHydroxylapatiteQualityChecker",
  "api": "Calcium Hydroxylapatite",
  "batchNumber": "CAHA-FILL-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "CAHA-FILL-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "CaHA_Content_Percent",
      "value": "30.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "MicrosphereSize_um",
      "value": "32.0",
      "unit": "µm",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Agglomerates_Percent",
      "value": "0.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "CarrierGel_pH",
      "value": "7.0",
      "unit": "pH",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Viscosity_Pa_s",
      "value": "18.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Syringeability_Force_N",
      "value": "12.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Impurity_FreeCalcium_ppm",
      "value": "20",
      "unit": "ppm",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

ID	Scenario	Expected result
TC-001	Valid CSV with expected header and sample row	All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002	A mandatory input.csv column is missing	Import is rejected or the row receives FAIL with schema reference.
TC-003	A numeric field contains text or a blank value	Type conversion error is recorded; the result is not hidden as PASS.
TC-004	A parameter is outside specification or critical limit	Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005	Positive pathogen/microbiological flag or microbiological limit excursion	Critical FAIL is produced with the offending parameter.
TC-007	Residual solvent above applicable limit	FAIL is produced with solvent name and measured value.

10. QA/QC, CSV and change control

Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
Column names must not be changed without updating the validator and test scenarios.
The source CSV, output.json and utility version should be stored together as an evidence package.
Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Dental & Dental Materials QC Suite

QC utility package for dental medicinal products, oral-care products and dental materials: anaesthetics, antiseptics, analgesic/anti-infective products, polymers/minerals, resins, bonding workflows, microbiology, stability and material QC.

Open

Dermal Fillers QC Suite

Package for injectable implants and dermal fillers: hyaluronic acid, CaHA, PLLA, PMMA, collagen and related tests.

Open

Proctology QC Suite

QC package for proctology: local anaesthetics, corticosteroids, anti-inflammatory, anti-infective and supporting medicines for rectal dosage forms.

Open